Immuno Oncology (I-O) Market [By Treatment Approaches (Monoclonal Antibodies, Therapeutic Vaccines, Checkpoint Inhibitors, and Cytokines); By Novel Targets (IDO1i, LAG-3 CPI, oncolytic virus, STING agonist, TLR agonist, HDACi, TIL, VEGFi, MEKi, TIGIT, CPI, GITR agonist, TGF-b trap, and A2AR antagonist/CD73i); By Tumor Types (Melanoma, Non-Small Cell Lung Cancer, Renal Cell Carcinoma, Head & Neck Cancer, Bladder Cancer, Classical Hodgkin’s Lymphoma and Merkel Cell Carcinoma); By Region]: Market
Select a license type that suits your business needs
Individual Price
US $5550
- Report Accessible Right to 1 User Only
- No Printing/Editing Rights
- 8 Hours of Post-sale Assistance by Market Analyst
- 5% or 16 Hours Customization
Enterprise Price
US $10550
- Report Accessible Rights to Unlimited Users
- Rights to Print/Edit
- 40 Hours of Post-Sales Assistance by Market Analyst
- 20% or 70 Hours Customization
- Direct Access to Lead Analyst
- Dedicated Account Manager
- 25% Discount on Next Report Purchase
- Free Report Overview on next Update within 1 year
- 1 year On-Demand Exclusive Preview Rights for Recent Developments in the Industry
Corporate Price
US $7550
- Report Accessible Rights to 5 Users
- Rights to Print/Edit
- 16 Hours of Post-Sales Assistance by Market Analyst
- 10% or 40 Hours Customization
- Direct Access to Lead Analyst
- Dedicated Account Manager
- 15% Discount on Next Report Purchase
